Responses
Clinical and epidemiological research
Concise report
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.